Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China · Delayed Price · Currency is CNY 25.33
-0.26 (-1.02%)
Jun 11, 2026, 1:02 PM CST
SHA:603351 Market Cap
SHA:603351 has a market cap or net worth of 3.47 billion as of June 10, 2026. Its market cap has decreased by -8.48% in one year.
Market Cap
3.47B
Enterprise Value
3.63B
Revenue
1.34B
Ranking
n/a
PE Ratio
22.85
Stock Price
25.33
Market Cap Chart
Since January 30, 2019, SHA:603351's market cap has increased from 3.41B to 3.47B, an increase of 1.70%. That is a compound annual growth rate of 0.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 3.47B | -1.65% |
| Dec 31, 2025 | 3.52B | 5.94% |
| Dec 31, 2024 | 3.33B | -6.86% |
| Dec 29, 2023 | 3.57B | 21.88% |
| Dec 30, 2022 | 2.93B | -42.75% |
| Dec 31, 2021 | 5.12B | 71.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Newland Pharmaceutical | 3.63B |
| Shanghai Xiao Fang Pharmaceutical | 3.56B |
| Sinotherapeutics | 3.56B |
| Shandong Wohua Pharmaceutical | 3.49B |
| Zhejiang Cheng Yi Pharmaceutical | 3.32B |
| Zhuhai Rundu Pharmaceutical | 3.32B |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 3.26B |
| Qianjiang Yongan Pharmaceutical | 3.22B |